One of the world’s leading vaccine manufacturing companies engaged us to independently verify their position as a leading player in hexavalent vaccines. The scope of the study is as follows:
• Hexavalent vaccine dosage patterns
• Immunization trends
• Vaccine co-use trends
• Current market share for hexavalent vaccines
• Market size and share of the client’s own hexavalent vaccine brand
A customized academic white paper was delivered, featuring:
Vaccine Market Overview
• Analysis of the vaccine market size and forecast
Hexavalent Vaccine Prescribing and Dosage Patterns
• Examination of prescribing trends and dosage patterns for hexavalent vaccines
Market Share and Size Analysis
• Assessment of hexavalent vaccine market share, size, and dosage volume
• Evaluation of the client’s hexavalent brand market size, dosage volume, and share
Brand Positioning Insights
• Detailed understanding of the client’s hexavalent brand position globally and in select countries
Recommendations & Conclusions
• Strategic recommendations and key conclusions based on the analysis
Secondary Research:
• Searched journals and publications related to vaccination to gather information on epidemiology and disease economics
• Reviewed WHO guidelines, GAVI databases, and other vaccine-specific information sources
Data Modelling:
• Used information gained from secondary research in conjunction with our proprietary database to create a model estimating the market size and shares for both hexavalent vaccines and the client’s brand
Primary Research:
• Conducted interviews with pediatricians and vaccine policy experts to strengthen understanding of the market and validate findings and analysis
Strategic and Marketing Support
• Delivered research findings and presentation that satisfied the client
• Provided information and analysis to support marketing claims and help shape strategy in countries of interest